Barbara Brizz

1.4k total citations · 1 hit paper
8 papers, 1.0k citations indexed

About

Barbara Brizz is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Barbara Brizz has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Virology and 2 papers in Emergency Medicine. Recurrent topics in Barbara Brizz's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). Barbara Brizz is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (4 papers). Barbara Brizz collaborates with scholars based in United States, India and Ireland. Barbara Brizz's co-authors include Kevin W. Garren, Donald I. Abrams, Douglas L. Mayers, A. Gregory DiRienzo, Umesh Lalloo, Richard Haubrich, Susan Swindells, William G. Powderly, James F. Rooney and Karin L. Klingman and has published in prestigious journals such as New England Journal of Medicine, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Barbara Brizz

8 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

2008 500 citations Sharon A. Riddler, Richard Haubrich et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Barbara Brizz

Since Specialization

Citations

This map shows the geographic impact of Barbara Brizz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Brizz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Brizz more than expected).

Fields of papers citing papers by Barbara Brizz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Brizz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Brizz. The network helps show where Barbara Brizz may publish in the future.

Co-authorship network of co-authors of Barbara Brizz

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Brizz. A scholar is included among the top collaborators of Barbara Brizz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Brizz. Barbara Brizz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-Infected Subjects ACTG 5200 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Michael F. Para, (unknown), Susan L. Rosenkranz, Yu Song, David B. Weiner, Pablo Tebas, C. J. White, Dominic N. Reeds, Juan J.L. Lertora, Kristine B. Patterson, Eric S. Daar, Winston Cavert, Barbara Brizz	9
2	Class-Sparing Regimens for Initial Treatment of HIV-1 Infection breakdown → 2008 ·New England Journal of Medicine ·Sharon A. Riddler, Richard Haubrich, A. Gregory DiRienzo, Lynne Peeples, William G. Powderly, Karin L. Klingman, Kevin W. Garren, (unknown), James F. Rooney, Barbara Brizz, Umesh Lalloo, Robert L. Murphy, Susan Swindells, Diane V. Havlir, John W. Mellors	500
3	Switching to a Protease Inhibitor-Containing, Nucleoside-Sparing Regimen (Lopinavir/Ritonavir Plus Efavirenz) Increases Limb Fat But Raises Serum Lipid Levels 2007 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Pablo Tebas, Jiameng Zhang, Kevin E. Yarasheski, Scott Evans, Margaret A. Fischl, Abby Shevitz, Judith Feinberg, Ann C. Collier, Cecilia M. Shikuma, Barbara Brizz, Fred R. Sattler	46
4	Effect of Highly Active Antiretroviral Therapy on Viral Burden in the Lungs of HIV‐Infected Subjects 2007 ·The Journal of Infectious Diseases ·Homer L. Twigg, Michael D. Weiden, Fred Valentine, Carol Schnizlein‐Bick, Roland L. Bassett, Lu Zheng, Joseph Wheat, Richard B. Day, (unknown), Ronald G. Collman, Lawrence Fox, Barbara Brizz, Joan Dragavon, Robert W. Coombs, R. Pat Bucy	40
5	Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen 2007 ·AIDS ·Margaret A. Fischl, Ann C. Collier, Aprateem Mukherjee, Judith Feinberg, Lisa M. Demeter, Pablo Tebas, Marina Giuliano, Marjorie Dehlinger, Kevin W. Garren, Barbara Brizz, Roland L. Bassett	20
6	Amprenavir and Efavirenz Pharmacokinetics before and after the Addition of Nelfinavir, Indinavir, Ritonavir, or Saquinavir in Seronegative Individuals 2005 ·Antimicrobial Agents and Chemotherapy ·Gene D. Morse, Susan L. Rosenkranz, Michael F. Para, Yoninah Segal, Robin DiFrancesco, Elizabeth L. Adams, Barbara Brizz, Kevin E. Yarasheski, Richard C. Reichman	13
7	The Rationale and Design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) Trial 2001 ·Controlled Clinical Trials ·Rodger D. MacArthur, Li Chen, Douglas L. Mayers, C. Lynn Besch, Richard M. Novak, Mary van den Berg-Wolf, (unknown), Grace Peng, Barry Schmetter, Barbara Brizz, Donald I. Abrams	31
8	A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy 2000 ·AIDS ·John D. Baxter, Douglas L. Mayers, Deborah Wentworth, James D. Neaton, Marie L. Hoover, Mark A. Winters, Sharon Mannheimer, Melanie Thompson, Donald I. Abrams, Barbara Brizz, John P. A. Ioannidis, Thomas C. Merigan	379

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact